Delivery Order SPE2DB20D2104-SPE2DB25FMJUS

Award Date 2/25/25
Potential Completion Date 2/26/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $70,718.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566817839 TADALAFIL 20 MG TABLET 60S, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,256.42, is for the delivery of 4562355533 TADALAFIL 5 MG TABLET 30S, which are prescription pharmaceuticals. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,150.13, is a delivery order for the supply of 4566947026 - TADALAFIL 5 MG TABLET 30S. It is a firm-fixed-price contract with a performance period through January 16, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $52,127.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,566,929,547 units of Tadalafil 20 mg Tablets, a medication used to treat various medical conditions. The contract has a Firm Fixed Price pricing type and an ultimate completion date of January 15, 2025. This award is not designated as a set-aside contract....
This federal contract award, valued at $1,092.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers the procurement of 4566373398 -...
The federal contract award SPE2DB22D2006|SPE2DB24FW0WD, valued at $73,667.94, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. This contract is for the delivery of 4564803538 - TADALAFIL 20 MG TABLET 30S. It is a firm fixed-price delivery order contract with a completion date of June 5, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999...
This federal contract award, valued at $163,056.83, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,960,377 units of Tadalafil 10 mg tablets, a medication used to treat various medical conditions. The contract is a Firm Fixed Price Delivery Order, with a performance period extending through June 21, 2024. This award is part of a larger Indefinite...
This federal contract award, with the ID SPE2DB22D3301|SPE2DB25FY0BN, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $57,413.06 and has a Firm Fixed Price pricing type. It is for the supply of 4567269530 - TADALAFIL 20 MG TABLET 60S, with a completion date of February 14, 2025. The contract does not have a set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,738.46, is for the procurement of TADALAFIL 20 MG TABLET 30S, a prescription medication. The contract is a Firm Fixed Price (FFP) delivery order with a completion date of February 7, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,796.93 firm fixed price delivery order covers the supply of 4566583674 - Tadalafil 20 mg Tablet 30s, with a performance period through December 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMJUS
    Delivery Order

This federal contract award, valued at $1,379.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TADALAFIL 20 MG TABLET 30S, a medication used to treat various medical conditions. The award has an ultimate completion date of February 26, 2025 and is a Firm Fixed Price Delivery Order contract.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award was not designated with a set-aside requirement, indicating open competition. No subcontractors were mentioned in the provided information.

Generated 5/27/25, 9:44 AM